Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M120Revenue (TTM) $M57.8Net Margin (%)-78.6Altman Z-Score-2.9
Enterprise Value $M74.8EPS (TTM) $-0.4Operating Margin %-22.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-4.5Pre-tax Margin (%)-78.6Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio2.6Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-7.1Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow2.7y-y EBITDA Growth Rate %--ROA % (ttm)-16.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M105ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with VVUS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VVUS is held by these investors:



VVUS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-22Sell161,800$1.112.7view
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-16Sell305,090$1.13.64view
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-13Sell176,410$1.112.7view
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-08Sell563,527$1.067.55view
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-03Sell78,633$1.121.79view
Varghese Santosh TChief Medical Officer 2017-01-28Sell429$1.112.7view
Varghese Santosh TChief Medical Officer 2016-12-31Sell13,790$1.121.79view
Varghese Santosh TChief Medical Officer, 10% Owner 2016-10-01Sell710$1.140view
Varghese Santosh TChief Medical Officer 2016-08-02Sell12,559$1.076.54view
Varghese Santosh TVP, Medical & Reg Affairs 2016-07-01Sell366$1.21-5.79view

Press Releases about VVUS :

Quarterly/Annual Reports about VVUS:

News about VVUS:

Articles On GuruFocus.com
Biotech Momentum Indicators: Achaogen (AKAO), Novartis (NVS), VIVUS (VVUS) Apr 01 2015 
5-year lows: PICO Holdings Inc, Black Box Corp, Vivus, and Electro Rent Corp. Mar 29 2015 
A Look at Pharma Company Dermira's Performance Mar 27 2015 
5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 08 2015 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Mar 25 2014 
Billionaires Hold Four Stocks, 59% Off Sep 30 2013 
Unique Investor Kyle Bass Unloads Five May 29 2013 
Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW Feb 24 2013 
Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 

More From Other Websites
No related articles found.

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)